Cart
sales@molnova.com
HA155
CAS No. 1312201-00-5
HA155 ( CS-963 )
Catalog No. M26244 CAS No. 1312201-00-5
HA155 selectively and potently inhibits autotaxin with an IC50 of 5.7 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 335 | Get Quote |
|
| 10MG | 494 | Get Quote |
|
| 25MG | 782 | Get Quote |
|
| 50MG | 1053 | Get Quote |
|
| 100MG | 1422 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHA155
-
NoteResearch use only, not for human use.
-
Brief DescriptionHA155 selectively and potently inhibits autotaxin with an IC50 of 5.7 nM.
-
DescriptionHA155 selectively and potently inhibits autotaxin with an IC50 of 5.7 nM.(In Vitro):HA155 completely attenuates the thrombin-mediated increase in platelet-derived LPA dose-dependently .HA155 is an ATX inhibitor by binding to the ATX active site .
-
SynonymsCS-963
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1312201-00-5
-
Formula Weight463.3
-
Molecular FormulaC24H19BFNO5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(CC2=CC=C(F)C=C2)C(S/C1=C\C3=CC=C(OCC4=CC=C(B(O)O)C=C4)C=C3)=O.[(Z)]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Guo B, et al. Clinical Pharmacokinetics of Levornidazole in Elderly Subjects and Dosing Regimen Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis. Clin Ther. 2017 Jul;39(7):1336-1346.
molnova catalog
related products
-
SEP-0372814
PDE10-IN-1 is PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1 for treating CNS and metabolic disorders.
-
GSK 256066 Trifluoro...
A potent, selective PDE4 inhibitor with pIC50 of 11.5, 11.3, 11.4, and 11.9 for PDE4B, A, C, and D, respectively.
-
Aminophylline
Aminophylline is a competitive nonselective phosphodiesterase inhibitor that is used to treat airway obstruction from asthma or COPD.
